samedan logo
 
 
 
spacer
home > pmps > summer 2018 > datwyler is ready for future challenges
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Datwyler Is Ready for Future Challenges

The requirements for drug and parenteral packaging are ever-evolving and constantly changing, especially due to the increasing number of biosimilars and biologics, as well as the appropriate administration. Elastomer components are a key element for parenteral packaging and, therefore, have to fulfil strict criteria in terms of chemical and functional performance.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
The Datwyler Group is an international supplier of stateof- the-art industrial components. In its Sealing Solutions division, Datwyler provides customised sealing solutions to manufacturers and companies in various industries. Within the healthcare unit, Datwyler develops, designs, and manufactures solutions for injectable packaging and drug delivery systems. The products and services of Datwyler are built on high-quality material, innovative technologies, outstanding engineering, and process know-how. The Datwyler Group has a global manufacturing footprint on three continents, sales in over 100 countries, and more than 7,000 employees. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future.
Print this page
Send to a friend
Privacy statement
News and Press Releases

First cellularized collagen membrane implant to regenerate heart tissue in patients with ischemic heart disease

• 3P Biopharmaceuticals and Viscofan go ahead with this innovative project of regenerative medicine for cardiac use • Beginning of Phase I clinical trial in a group of 10 patients
More info >>

White Papers

Antibody Internalization: Advanced Flow Cytometry and Live-Cell Analysis Give Rich Insights During Antibody Profiling

Sartorius Group

The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement